Список литературы
1. Aziz Q, Fass R, Gyawali CP, et al. Esophageal disorders. Gastroenterology. 2016;150(6):1368-1379. doi. 10.1053/j.gastro.2016.02.012.
2. Benninga MA, Rosen R, Borrelli О. Pediatric Disorders of Gut-Brain Interaction: Upper Gastrointestinal Disorders: Rome V Pediatric Disorders of Gut-Brain Interaction. 2nd ed. Raleigh: Rome Foundation. 2026. Р.:35-61.
3. Bilgi M, Vardar R, Yildirim E, Veznedaroğlu В, Bor S. Prevalence of psychiatric comorbidity in symptomatic gastroesophageal reflux subgroups. Digestive Diseases and Sciences. 2017;62:984-993. doi: 10.1007/s10620-016-4273-4.
4. Blasi E, Stefanelli E, Tambucci R, et al. Prevalence of non-erosive esophageal phenotypes in children: a European multicenter study. J Neurogastroenterol Motil. 2023;29(2):156-165. doi: 10.5056/jnm22115.
5. Dellon ES, Liacouras CA, Molina-Infante J, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE Conference. Gastroenterology. 2018;(4):1022-1033. doi: 10.1053 /j. gastro.2018.07.009.
6. Drossman DA, Chang L, Tack J. Disorders of Gut-Brain Interaction and the Rome V Process. Gastroenterology. 2026;170(6):1083-1098. doi: 10.1053/j.gastro.2026.02.014.
7. Farmer AD, Ruffle JK, Aziz Q. The Role of Esophageal Hypersensitivity in Functional Esophageal Disorders. J Clin Gastroenterol. 2017 Feb;51(2):91-99. doi: 10.1097/MCG.0000000000000757.
8. Franciosi JP, Mougey EB, Williams A, et al. Association between CYP2C19 extensive metabolizer phenotype and childhood anti-reflux surgery following failed proton pump inhibitor medication treatment. Eur J Pediatr. 2018;177(1):69-77. doi: 10.1007/s00431-017-3051-4.
9. Frazzoni I, Frazzoni M, De Bortoli N, et al. Application of Lyon Consensus criteria for GORD diagnosis: evaluation of conventional and new impedance-pH parameters. Gut. 2021;71:1062-1066. doi: 10.1136/gutjnl-2021-325531.
10. Glasinovic E, Wynter E, Arguero J. Treatment of supragastric belching with cognitive behavioral therapy improves quality of life and reduces acid gastroesophageal reflux. Am J Gastroenterol. 2018;113(4):539-547. doi: 10.1038/ajg.2018.15.
11. Gunasagaran HL, Varjavandi V, Lemberg DA, et al. The utility of multichannel intraluminal impedance-pH testing in tailoring the ma–nagement of paediatric gastro-oesophageal reflux disease. Acta Paediatr. 2020;109(12):2799-2807. doi: 10.1111/apa.15317.
12. Gyawali P, Roman S, Zerbib F, et al. Functional Esophageal Disorders. Gastroenterology. 2026;170(6):1224-1239. doi: 10.1053/j.gastro.2026.02.005.
13. Hyams Jeffrey S, Lorenzo Carlo Di, Saps Miguel. Childhood Functional Gastrointestinal Disorders: Child Adolescent. Gastroentero–logy. 2016;150:1456-1468. doi: 10.1053/j.gastro.2016.02.015.
14. Kia L, Pandolfino JE, Kahrilas PJ. Biomarkers of reflux di–sease. Clin Gastroenterol Hepatol. 2016;14(6):790-797. doi: 10.1016/j.cgh.2015.09.014.
15. Lee ALH, Varjavandi V, Lemberg DA, et al. Does combined multichannel intraluminal impedance and pH (MIIpH) testing improve clinical outcomes in children with gastroesophageal reflux disease? J Pediatr Gastroenterol Nutr. 2020;71(5):596-603. doi: 10.1097/MPG.0000000000002851.
16. Limarivijai L, Chatcharoenwiwatana P, Pausawasdi N, et al. Imipramine for treatment of esophageal hypersensitivity and functional heartburn: a randomized placebo-controlled trial. Am J Gastroenterol. 2016;111:217-224. doi: 10.1038/ajg.2015.413.
17. Li X, Ding F, Luo P, et al. Study on the therapeutic effects of drug and cognitive-behavioral therapy on nonerosive reflux disease patients with emotional disorders. Front Psychiatry. 2018;9:115. doi: 10.3389/fpsyt.2018.00115.
18. Losa Marco, Manz Salomon M, Schindler Valeria, et al. Increased visceral sensitivity, elevated anxiety, and depression levels in patients with functional esophageal disorders and non-erosive reflux disease. Neurogastroenterol Motil. 2021;33(9):e14177. doi: 10.1111/nmo.14177.
19. Mahoney LB, Nurko S, Rosen R. The prevalence of Rome IV nonerosive esophageal phenotypes in children. J Pediatr. 2017:189:86-91. doi: 10.1016/j.jpeds.2017.06.019.
20. Mahoney LB, Rosen R. The spectrum of reflux phenotypes. Gastroenterol Hepatol (NY). 2019;15:648-654. PMCID: PMC6935024. PMID: 31892911.
21. Masui D, Nikaki K, Sawada A, et al. Belching in children: prevalence and association with gastroesophageal reflux disease. Neurogastroenterol Motil. 2021;34(1):e14194. doi: 10.1111/nmo.14194.
22. Nikaki K, Lee C, Ustaoglu A, et al. Esophageal mucosa innervation in children with nonerosive reflux disease. Am J Gastroenterol. 2021;116(8):1727-1729. doi: 10.14309/ajg.0000000000001286.
23. Nikaki K, Sawada A, Ustaoglu A, et al. Neuronal Control of Esophageal Peristalsis and Its Role in Esophageal Disease. Current Gastroenterology Reports. 2019;21:59. doi: 10.1007/s11894-019-0728-z.
24. Patel A, Hasak S, Nix BD, et al. Genetic risk factors for perception of symptoms in GERD: an observational cohort study. Aliment Pharmacol Ther. 2018;47(2):289-297. doi: 10.1111/apt.14414.
25. Peralta-Palmezano JJ, Guerrero-Lozano R. Prevalence of functional gastrointestinal disorders in school children and adolescents. Korean J Gastroenterol. 2019;25;73(4):207-212. doi: 10.4166/kjg.2019.73.4.207.
26. Popa Stefan L, Surdea-Blaga Teodora, David Liliana. Supragastric belching: Pathogenesis, diagnostic issues and treatment. Saudi J Gastroenterol. 2022;28(3):168-174. doi: 10.4103/sjg.sjg_405_21.
27. Punkkinen J, Nyyssonen M, Walamies M, et al. Behavioral therapy is superior to follow-up without intervention in patients with supragastric belching — А randomized study. Neurogastroenterol Motil. 2022;34(2): e14171. doi: 10.1111/nmo.14171.
28. Pur Neetu Functional Esophageal Disorders in Children. Gastroenterol Clin North Am. 2025 Sep;54(3):503-510. doi: 10.1016/j.gtc.2025.06.001.
29. Rajindrajith S, Gunawardane D, Kuruppu C, et al. Epidemiology of aerophagia in children and adolescents: a systematic review and meta-analysis. PLoS One 2022;17:e0271494. doi: 10.1371/journal.pone.0271494.
30. Oude Nijhuis RAB, Curvers WL, van der Ende M. Utility of Routine Esophageal Biopsies in Patients With Refractory Reflux Symptoms. The American Journal of Gastroenterology. 2012;116(4):816-820. doi: 10.14309/ajg.0000000000001064.
31. Riehl ME, Pandolfino JE, Palsson OS, et al. Feasibility and acceptability of esophageal-directed hypnotherapy for functional heartburn. Dis Esophagus. 2016;29(5):490-6. doi: 10.1111/dote.12353.
32. Rosen R, Borrelli O, Faure C, et al. Rome V Pediatric Upper Gastrointestinal Disorders of Gut-Brain Interaction. Gastroenterology. 2026;170(6):1347-1366. doi: 10.1053/j.gastro.2026.01.039.
33. Rosen R, Vandenplas Y, Singendonk M, et al. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66(3):516-554. doi: 10.1097/MPG.0000000000001889.
34. Rouster AS, Karpinski AC, Silver D, et al. Functional gastrointestinal disorders dominate pediatric gastroenterology outpatient practice. J Pediatr Gastroenterol Nutr. 2016;62:847-851. doi: 10.1097/MPG.0000000000001023.
35. Saps M, Velasco-Benitez CA, Blom PJJ, et al. Prospective study of gastrointestinal symptoms in school children of South Ame–rica. J Pediatr Gastroenterol Nutr. 2018;66:391-394. doi: 10.1097/MPG.0000000000001720.
36. Sawada A, Fujiwara Y, Sifrim D. Belching in Gastroesophageal Reflux Disease: Literature Review. J Clin Med. 2020;9(10):3360; doi.org/10.3390/jcm9103360.
37. Scarpato E, Kolacek S, Jojkic-Pavkov D, et al. Prevalence of functional gastrointestinal disorders in children and adolescents in the Mediterranean region of Europe. Clin Gastroenterol Hepatol. 2018;16(6):870-876. doi: 10.1016/j.cgh.2017.11.005.
38. Tack J, Pandolfino J. Pathophysiology of Gastroesophageal Reflux Disease. Gastroenterology. 2018;154(2):277-288. doi: 10.1053/j.gastro.2017.09.047.
39. Taft TH, Triggs JR, Carlson DA, et al. Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal disease. Aliment Pharmacol Ther. 2018;47(9):1270-1277. doi: 10.1111/apt.14605.
40. Ten Cate L, Herregods TVK, Dejonckere PH, et al. Speech therapy as treatment for supragastric belching. Dysphagia. 2018;33(5):707-715. doi: 10.1007/s00455-018-9890-y.
41. Ustaoglu A, Sawada A, Lee C, et al. Heartburn sensation in nonerosive reflux disease: pattern of superficial sensory nerves expres–sing TRPV1 and epithelial cells expressing ASIC3 receptors. Am J Physiol Gastrointest Liver Physiol. 2021;320:G804-G815. doi: 10.1152/ajpgi. 00013.2021.
42. Ustaoglu А, Nguyen А, Spechler S, et al. Mucosal pathogenesis in gastro-esophageal reflux disease. Neurogastroenterology & Motility. 2020;32:e14022. doi.org/10.1111/nmo.14022.
43. van Lennep M, Lansink F, Benninga MA, et al. Agedependent normal values for the ‘Infant Gastroesophageal Reflux Questionnaire Revised’. Eur J Pediatr. 2024;183(1):445-452. doi: 10.1007/s00431-023-05281-w.
44. Wong MW, Liu TT, Yi CH, et al. Oesophageal hypervigilance and visceral anxiety relate to reflux symptom severity and psychological distress but not to acid reflux parameters. Aliment Pharmacol Ther. 2021;54(7):923-930. doi: 10.1111/apt.16561.
45. Woodland P, Shen Ooi JL, Grassi F, et al. Superficial esophageal mucosal afferent nerves may contribute to reflux hypersensitivity in nonerosive reflux disease. Gastroenterology. 2017;153(5):1230-1239. doi: 10.1053/j.gastro.2017.07.017.
46. Woodley FW, Ciciora SL, Vaz K. Novel Use of Impedance Technology Shows That Esophageal Air Events Can Be Temporally Associated With Gastroesophageal Reflux Disease-like Symptoms. J Pediatr Gastroenterol Nutr. 2020;70(1):e7-e11. doi: 10.1097/MPG.0000000000002514.
47. Zad M, Bredenoord AJ. Chronic burping and belching. Curr Treat Options Gastroenterol. 2020;18:33-42. doi: 10.1007/s11938-020-00276-0.